When we combined mutations of ZFP36L2 and ZFP36 to ZFP36L1, the frequency of ZFP36 gene family mutations reached 3% (n = 297) in all TCGA cohorts, with the highest frequencies observed in bladder cancers (Additional file 2: Fig. S3c). The gene discussed is ZFP36L2; the disease is urinary bladder cancer.